CHERRY HILL, N.J., May 05, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq:VYNT), an innovative biotechnology company reinventing drug discovery for complex neurodevelopmental and neurodegenerative disorders, announced that Jay Roberts, Chief Executive Officer, will present at BioNJ’s 12th Annual BioPartnering Conference. One-on-one partnering meetings will be held throughout the week (May 9-13, 2022). An on-demand replay of Vyant Bio’s presentation will be available to registered guests.
Read more at globenewswire.comVyant Bio Announces Participation in BioNJ’s 12th Annual BioPartnering Conference
Globe Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
/The%20sign%20for%20Marvell%20Technology%20out%20front%20of%20a%20corporate%20office%20by%20Valeriya%20Zankovych%20via%20Shutterstock.jpg)
/Microsoft%20Corporation%20logo%20on%20sign-by%20Jean-Luc%20Ichard%20via%20iStock.jpg)
